[Editors' Choice] Neutralizing antibodies for AAV vectors: The strange case of AAV5

A clinical trial on hemophilia B demonstrated efficient liver targeting with AAV5 in the presence of neutralizing antibodies.

Source: Science Translational Medicine - June 18, 2019 Category: Biomedical Science Authors: Ronzitti, G. Tags: Editors ' Choice Source Type: research